This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Stay updated with the latest weekly cash back credit card deals to maximize your savings. Don't miss these offers!
23,042 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Investors are turning away from Hewlett Packard Enterprise as a dividend-rich tech giant with a clearer AI roadmap ga...
The Trade Desk just fell to a multi-year low, sparking a debate between momentum fans and value hunters. This guide b...
Foreign R&D drives innovation across borders, but it carries subtle tax costs that can eat into profits. This guide e...
A rising fintech stock year story shows profits climbing while a major fund trims nearly $300M from its stake. The mo...
Risk-off sentiment is weighing on the Nasdaq as tech names retreat. This guide explains what’s moving the stock marke...
Two software powerhouses offer very different paths: a hospitality-focused platform and a broad CRM suite. This guide...
Dividend income investors watch yields closely. This article explains how yields move, why this dividend ETF's yield ...
Vale’s shares fell as iron ore demand in China cooled, signaling wider margin pressures for metals. This guide breaks...
In this millionaire interview, a real couple shares how they built a multi-million net worth through disciplined savi...
NuScale Power has seen wild swings, but the story isn’t just nostalgia for a boom. This piece breaks down the odds of...
Sunrun’s Thursday rally followed a robust first-quarter report, highlighting strong revenue growth and a surge in ene...